LSBio
Luciferase Antibody

Western Blot of Goat anti-Luciferase Antibody. Lane 1: Luciferase (Firefly). Load: 50 ng per lane. Primary antibody: Goat anti-Luciferase Antibody at 1:1,000 overnight at 4°C. Secondary antibody: HRP goat secondary antibody at 1:40,000 for 30 min at RT.

Luciferase Antibody

Primary AntibodyLSBio Guarantee
Antibody:Goat Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Western Blot
Reactivity:Arthropod (Insect / Arachnid / Crustacean)
Format:Lyophilized
See all Photinus pyralis Luciferase antibodies →
$541.00each
Catalog Number: LS-C153961-2

For bulk orders or custom formulations:

Request a Quote

Overview

Description
Luciferase antibody LS-C153961 is an unconjugated goat polyclonal antibody to Luciferase from photinus pyralis. It is reactive with firefly and photinus pyralis. Validated for ELISA and WB. Cited in 1 publication.
Application
ELISA, WB
Reactivity
Arth
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Recommended Dilution: ELISA
1:20000 - 1:100000
Recommended Dilution: WB
1:2000 - 1:10000

Target

Target
Photinus pyralis Luciferase
Antigen Species
Arthropod (Insect / Arachnid / Crustacean)
Epitope
Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-goat serum, purified and partially purified Luciferase [Firefly]. No reactivity is observed against Sea pansy (Renilla reniformis) luciferase.

Antibody

Host Species
Goat
Clonality
Polyclonal

Immunogen

Immunogen
Luciferase [Firefly].

Format

Conjugate/Label
Unconjugated
Format
Lyophilized
Formulation
Lyophilized from 0.02 M Potassium Phosphate, pH 7.2, 0.15 M NaCl, 0.01% Sodium Azide
Concentration
82 mg/mL
Volume
2 Milliliter
Preservative
Yes
Purification Method
Other

Storage & Handling

Storage Conditions
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
0.02 M Potassium Phosphate|0.15 M NaCl
Identification of target cells for the genomic effects of estrogens in bone. Windahl SH, Lagerquist MK, Andersson N, Jochems C, Kallkopf A, Hkansson C, Inzunza J, Gustafsson JA, van der Saag PT, Carlsten H, Pettersson K, Ohlsson C. Endocrinology. 2007;148:5688-95. PubMed: 17761761

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.